Free shipping on all orders over $ 500

GPR39-C3

Cat. No. M6150

All AbMole products are for research use only, cannot be used for human consumption.

GPR39-C3 Structure
Synonym:

TC-G-1008

Size Price Availability Quantity
1mg USD 40  USD40 In stock
5mg USD 105  USD105 In stock
10mg USD 180  USD180 In stock
25mg USD 360  USD360 In stock
50mg USD 620  USD620 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: TC-G-1008 shows selectivity over a panel of kinases (IC50s>10 μM) and does not exhibit relevant binding affinity for the related ghrelin and neurotensin-1 receptors (IC50s>30 μM). In HEK293-GPR39 cells, GPR39-C3, which is a positive allosteric modulator, activates cAMP production (downstream of Gs), IP1 accumulation (downstream of Gq), SRF-RE-dependent transcription (downstream of G12/13), and β-arrestin recruitment. GPR39-C3 induces dose- and time-dependent loss of response in cAMP production by second challenge of the compound.

In vivo: Rat and mouse plasma protein binding for TC-G-1008 is measured as 99.3% and 99.1%, respectively. TC-G-1008 is orally bioavailable in mice and robustly induces acute GLP-1 levels. Upon single oral doses of 10, 30, and 100 mg/kg of aqueous suspensions in 0.5% methylcellulose/0.1% Tween 80, TC-G-1008 achieves, between 1 and 1.5 h, maximal exposures of 1.4, 6.1, and 25.3 μM, respectively.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Rat
Formulation 0.5% methylcellulose/0.1% Tween 80
Dosages 10, 30, and 100 mg/kg
Administration oral
Chemical Information
Molecular Weight 418.9
Formula C18H19ClN6O2S
CAS Number 1621175-65-2
Solubility (25°C) 100 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shimizu Y, et al. Biochem Pharmacol. Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation.

[2] Sato S, et al. Mol Pharmacol. Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.

Related GPR/FFAR Products
GPR84 antagonist 8 

GPR84 antagonist 8 is a selective GPR84 antagonist.

ML191

ML-191 is an antagonist of GPR55.

CID1172084 

CID1172084 is a selective GPR55 agonist (EC50=0.16 μM).

ML 145 

ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM.

PSN 375963 hydrochloride 

PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: GPR39-C3, TC-G-1008 supplier, GPR/FFAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.